【at what humidity do swamp coolers stop working】Taking A Look At Garofalo Health Care S.p.A.’s (BIT:GHC) ROE
While some investors are already well versed in financial metrics (hat tip),at what humidity do swamp coolers stop working this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we’ll use ROE to better understand Garofalo Health Care S.p.A. (
BIT:GHC
).
Our data shows
Garofalo Health Care has a return on equity of 14%
for the last year. One way to conceptualize this, is that for each €1 of shareholders’ equity it has, the company made €0.14 in profit.
See our latest analysis for Garofalo Health Care
How Do I Calculate Return On Equity?
The
formula for return on equity
is:
Return on Equity = Net Profit ÷ Shareholders’ Equity
Or for Garofalo Health Care:
14% = 15.049 ÷ €111m (Based on the trailing twelve months to June 2018.)
It’s easy to understand the ‘net profit’ part of that equation, but ‘shareholders’ equity’ requires further explanation. It is the capital paid in by shareholders, plus any retained earnings. The easiest way to calculate shareholders’ equity is to subtract the company’s total liabilities from the total assets.
What Does ROE Signify?
ROE measures a company’s profitability against the profit it retains, and any outside investments. The ‘return’ is the profit over the last twelve months. A higher profit will lead to a higher ROE. So, all else equal,
investors should like a high ROE
. That means it can be interesting to compare the ROE of different companies.
Does Garofalo Health Care Have A Good ROE?
Arguably the easiest way to assess company’s ROE is to compare it with the average in its industry. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. If you look at the image below, you can see Garofalo Health Care has a similar ROE to the average in the Healthcare industry classification (14%).
BIT:GHC Last Perf January 1st 19
That’s neither particularly good, nor bad. ROE can give us a view about company quality, but many investors also look to other factors, such as whether there are insiders buying shares. If you like to buy stocks alongside management, then you might just love this
free
list of companies. (Hint: insiders have been buying them).
Why You Should Consider Debt When Looking At ROE
Companies usually need to invest money to grow their profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders’ equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.
Story continues
Combining Garofalo Health Care’s Debt And Its 14% Return On Equity
Garofalo Health Care has a debt to equity ratio of 0.45, which is far from excessive. The fact that it achieved a fairly good ROE with only modest debt suggests the business might be worth putting on your watchlist. Conservative use of debt to boost returns is usually a good move for shareholders, though it does leave the company more exposed to interest rate rises.
In Summary
Return on equity is useful for comparing the quality of different businesses. In my book the highest quality companies have high return on equity, despite low debt. All else being equal, a higher ROE is better.
Having said that, while ROE is a useful indicator of business quality, you’ll have to look at a whole range of factors to determine the right price to buy a stock. It is important to consider other factors, such as future profit growth — and how much investment is required going forward. So you might want to check this FREE
visualization of analyst forecasts for the company
.
But note:
Garofalo Health Care may not be the best stock to buy
. So take a peek at this
free
list of interesting companies with high ROE and low debt.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
(责任编辑:Knowledge)
- EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Tops Revenue Estimates
- Zacks Rank #5 Additions for Monday
- Exclusive - Indonesia hopes for additional $10 bilion inflows after S&P upgrade, president says
- Before You Buy China Soft Power Technology Holdings Limited (HKG:139), Consider Its Volatility
- Galleon Gold Acquires Additional Interest in the Neal Gold Project and Increases Previously Announced Private Placement
- 5 Best Performing Stocks of the Top ETF of 2018
- 4 Connecticut Attorneys Disciplined for Forgery, Assault and Other Offenses
- ETF Chart of the Day: Philippines
- Sientra to Present at the William Blair 40th Annual Growth Stock Conference
- Pharrell’s Next Solo LP Will Be Rap-Free
- How Much Are Uni-Select Inc. (TSE:UNS) Insiders Spending On Buying Shares?
- Fatalities on commercial passenger aircraft rise in 2018
- Nokia draws $560 million R&D loan for 5G
- Maritime Announces Board and Management Changes
- InvestmentPitch Media Video Discusses Recent eResearch Buy Recommendation on Peak Positioning Technologies, Parent Company of a Group of FinTech Subsidiaries operating in China - Video Available on Investmentpitch.com
- BRIEF-Suzhou Longjie Special Fiber Sets Pricing For Its Shanghai IPO
- Could The IXUP Limited (ASX:IXU) Ownership Structure Tell Us Something Useful?
- Pinnacle West Capital (PNW) Lags Q1 Earnings - Tale of the Tape
- Hedge Funds Aren’t Done Buying Tech Data Corp (TECD)
- Laverne Cox Recalls 'Trauma' of Watching Loved Ones Die of HIV/AIDS and Wondering, 'Am I Next?'